Holding

Bio-Path Holdings Announces 1-for-20 Reverse Stock Split

Retrieved on: 
Wednesday, February 21, 2024

Upon the effectiveness of the reverse stock split, every 20 shares of common stock issued and outstanding as of the effective date will be automatically combined into one share of common stock.

Key Points: 
  • Upon the effectiveness of the reverse stock split, every 20 shares of common stock issued and outstanding as of the effective date will be automatically combined into one share of common stock.
  • No fractional shares of common stock will be issued in connection with the reverse stock split.
  • The reverse stock split will not change the par value of the common stock or modify the rights or preferences of the common stock.
  • The Company anticipates that the reverse stock split will reduce the number of shares of the Company’s common stock issued and outstanding from 12,352,664 shares to approximately 617,833 shares.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of WNS (Holdings) Limited - WNS

Retrieved on: 
Tuesday, February 20, 2024

NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of WNS (Holdings) Limited (“WNS” or the “Company”) (NYSE: WNS).

Key Points: 
  • NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of WNS (Holdings) Limited (“WNS” or the “Company”) (NYSE: WNS).
  • The investigation concerns whether WNS and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On February 2, 2024, WNS disclosed that “one of [WNS’s] top five customers by revenue contribution in fiscal 2024 .
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Maiden Holdings, Ltd. to Release Fourth Quarter 2023 Earnings on March 12, 2024

Retrieved on: 
Tuesday, March 5, 2024

Maiden Holdings, Ltd. ("Maiden") (NASDAQ: MHLD) announced it plans to release its fourth quarter 2023 financial results after the market closes on Tuesday, March 12, 2024.

Key Points: 
  • Maiden Holdings, Ltd. ("Maiden") (NASDAQ: MHLD) announced it plans to release its fourth quarter 2023 financial results after the market closes on Tuesday, March 12, 2024.
  • Maiden’s results will be released by posting the news release to its web site and providing public notice of the availability of the earnings release.

Xerox Announces Tender Offers for 2024 Notes and 2025 Notes

Retrieved on: 
Monday, March 4, 2024

Subject to the terms and conditions set forth in the offer to purchase, dated March 4, 2024 (as it may be amended or supplemented from time to time, the "Offer to Purchase"), (a) Holdings is offering to purchase for cash an aggregate principal amount of its 5.000% senior notes due 2025 (the “2025 Notes”) up to $94 million (such cap, the “Maximum Tender Cap”) (the “Maximum Tender Offer”) and (b) Xerox is offering to purchase for cash any and all of its 3.800% senior notes due 2024 (the “2024 Notes”) (the “Any and All Tender Offer” and, together with the Maximum Tender Offer, the “Tender Offers”).

Key Points: 
  • Subject to the terms and conditions set forth in the offer to purchase, dated March 4, 2024 (as it may be amended or supplemented from time to time, the "Offer to Purchase"), (a) Holdings is offering to purchase for cash an aggregate principal amount of its 5.000% senior notes due 2025 (the “2025 Notes”) up to $94 million (such cap, the “Maximum Tender Cap”) (the “Maximum Tender Offer”) and (b) Xerox is offering to purchase for cash any and all of its 3.800% senior notes due 2024 (the “2024 Notes”) (the “Any and All Tender Offer” and, together with the Maximum Tender Offer, the “Tender Offers”).
  • The Company refers investors to the Offer to Purchase for the complete terms and conditions of the Tender Offers.
  • The full details of the Tender Offers, including complete instructions on how to tender Securities, are included in the Offer to Purchase.
  • This press release shall not constitute an offer to purchase or a solicitation of an offer to purchase the 2024 Notes or the 2025 Notes.

Technology Holdings advises Leonardo, a leading Australian Automation, BPM & Business Process Transformation Specialist, on its strategic sale to UST, a Temasek portfolio company

Retrieved on: 
Monday, March 4, 2024

Leonardo, a trusted partner of UiPath, Automation Anywhere, Red Hat, Software AG, and Workato, excels at driving comprehensive intelligent process improvements using cutting-edge technology.

Key Points: 
  • Leonardo, a trusted partner of UiPath, Automation Anywhere, Red Hat, Software AG, and Workato, excels at driving comprehensive intelligent process improvements using cutting-edge technology.
  • Leonardo helps clients rebuild their processes for the digital age by combining process-centric strategic thinking with the rigour and precision of enabling technologies that support their transformation.
  • “Leonardo engaged Technology Holdings to run a process for the shareholders to achieve a liquidity event, and for our staff to have enhanced career opportunities.
  • Through the ups and downs of the transaction process, Technology Holdings always providing a solid commercial sounding board that helped the shareholders of Leonardo achieve the outcome they desired.

dentalcorp Announces Release Date for Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, March 4, 2024

dentalcorp Holdings Ltd. ("dentalcorp" or the "Company") (TSX: DNTL), Canada's largest and one of North America's fastest growing networks of dental practices, announced today that it will release its fourth quarter and full year 2023 financial results before market open on March 22, 2024.

Key Points: 
  • dentalcorp Holdings Ltd. ("dentalcorp" or the "Company") (TSX: DNTL), Canada's largest and one of North America's fastest growing networks of dental practices, announced today that it will release its fourth quarter and full year 2023 financial results before market open on March 22, 2024.
  • The Company will subsequently hold a conference call to provide a business update on Friday, March 22, 2024, at 8:30 a.m.
  • ET.
  • A question-and-answer session will follow the business update.

dentalcorp Announces Leadership Changes

Retrieved on: 
Thursday, February 29, 2024

dentalcorp Holdings Ltd. (“dentalcorp” or the “Company”) (TSX: DNTL), Canada’s largest and one of North America’s fastest-growing networks of dental practices, today announced that its President, Guy Amini, is stepping down effective immediately.

Key Points: 
  • dentalcorp Holdings Ltd. (“dentalcorp” or the “Company”) (TSX: DNTL), Canada’s largest and one of North America’s fastest-growing networks of dental practices, today announced that its President, Guy Amini, is stepping down effective immediately.
  • “On behalf of everyone at dentalcorp, I want to thank Guy for his leadership and dedication in his various roles with dentalcorp over the past 10 years.
  • Under Mr. Mosher’s leadership, ClearChoice grew into the largest provider of dental implants in North America, ultimately being acquired by The Aspen Group for over a billion US dollars.
  • Mr. Rosenberg added, “Kevin’s extensive industry experience will be invaluable to dentalcorp as we continue to strengthen our leadership team to support our growth ambitions.

Luxfer Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Guidance

Retrieved on: 
Wednesday, February 28, 2024

Luxfer Holdings PLC (NYSE: LXFR) (“Luxfer” or the “Company”), a global industrial company innovating niche applications in materials engineering, today announced financial results for the fourth quarter and full year, ended December 31, 2023.

Key Points: 
  • Luxfer Holdings PLC (NYSE: LXFR) (“Luxfer” or the “Company”), a global industrial company innovating niche applications in materials engineering, today announced financial results for the fourth quarter and full year, ended December 31, 2023.
  • “I am also pleased with the momentum and progress made in our strategic review process, which we announced in October.
  • Fourth quarter GAAP gross profit declined $5.2 million to $16.7 million.
  • Excluding Graphic Arts, adjusted EBITDA of $8.1 million decreased 27.7%, from $11.2 million in the prior year quarter.

Sally Beauty Holdings Announces the Completion of a Registered Public Offering of $600 Million of Senior Notes Due 2032

Retrieved on: 
Tuesday, February 27, 2024

Sally Holdings LLC (“Holdings”) and Sally Capital Inc. (together with Holdings, the “Issuers”), wholly-owned subsidiaries of Sally Beauty Holdings, Inc. (the “Company”) (NYSE: SBH), today announced the completion of a registered public offering of $600.0 million aggregate principal amount of Senior Notes due 2032 (the “Senior Notes”).

Key Points: 
  • Sally Holdings LLC (“Holdings”) and Sally Capital Inc. (together with Holdings, the “Issuers”), wholly-owned subsidiaries of Sally Beauty Holdings, Inc. (the “Company”) (NYSE: SBH), today announced the completion of a registered public offering of $600.0 million aggregate principal amount of Senior Notes due 2032 (the “Senior Notes”).
  • The Senior Notes are guaranteed by the Company, Sally Investment Holdings LLC and certain other domestic subsidiaries of the Company.
  • BofA Securities, J.P. Morgan and Truist Securities served as joint book-running managers for the offering.
  • This press release shall not constitute a notice of redemption with respect to the notes being redeemed.

Technology Holdings Launches TH Healthcare & Life Sciences: Revolutionizing the Healthcare Investment Banking Landscape, leveraging over two decades of Healthcare Investment Banking transaction experience

Retrieved on: 
Tuesday, February 27, 2024

Technology Holdings , a global investment bank with offices in North America, Europe and the Asia-Pacific, proudly announces the launch of TH Healthcare & Life Sciences , its specialist healthcare investment banking division.

Key Points: 
  • Technology Holdings , a global investment bank with offices in North America, Europe and the Asia-Pacific, proudly announces the launch of TH Healthcare & Life Sciences , its specialist healthcare investment banking division.
  • TH Healthcare & Life Sciences will leverage Technology Holdings 23 years of healthcare transaction expertise, global reach with a presence in 9 countries and deep healthcare and life sciences sector knowledge.
  • TH Healthcare & Life Sciences leverages decades of relationships with key healthcare strategic buyers and private equity funds with a specialized, dedicated team of healthcare investment bankers allowing TH Healthcare & Life Sciences to strategically position healthcare and life sciences businesses and continue to achieve outstanding results for its clients.
  • “We are excited to announce the launch of TH Healthcare & Life Sciences, serviced by a dedicated team of healthcare investment bankers globally across 9 countries and 5 continents.